Forum Financial Management LP Grows Stock Holdings in Sanofi (NASDAQ:SNY)

Forum Financial Management LP grew its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 76.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 66,827 shares of the company's stock after buying an additional 28,879 shares during the quarter. Forum Financial Management LP's holdings in Sanofi were worth $3,223,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Arkadios Wealth Advisors grew its stake in shares of Sanofi by 19.0% during the fourth quarter. Arkadios Wealth Advisors now owns 4,709 shares of the company's stock valued at $227,000 after buying an additional 751 shares during the last quarter. Kentucky Trust Co bought a new position in shares of Sanofi during the fourth quarter valued at about $436,000. Van ECK Associates Corp grew its stake in shares of Sanofi by 18.1% during the fourth quarter. Van ECK Associates Corp now owns 662,762 shares of the company's stock valued at $31,965,000 after buying an additional 101,726 shares during the last quarter. Sound Income Strategies LLC boosted its holdings in shares of Sanofi by 156,520.9% during the fourth quarter. Sound Income Strategies LLC now owns 67,347 shares of the company's stock worth $3,248,000 after purchasing an additional 67,304 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Sanofi by 128.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 115,330 shares of the company's stock worth $5,558,000 after purchasing an additional 64,747 shares during the period. 14.04% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Hsbc Global Res upgraded shares of Sanofi to a "strong-buy" rating in a report on Monday, April 28th. BNP Paribas assumed coverage on shares of Sanofi in a report on Tuesday, April 15th. They set an "outperform" rating and a $65.00 target price for the company. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a "sell" rating to a "hold" rating in a report on Thursday, January 30th. The Goldman Sachs Group assumed coverage on shares of Sanofi in a report on Friday, March 21st. They set a "neutral" rating and a $65.00 target price for the company. Finally, Sanford C. Bernstein upgraded shares of Sanofi to a "strong-buy" rating in a report on Thursday, January 30th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of "Buy" and an average price target of $63.33.

Sanofi Trading Down 0.8%

SNY stock traded down $0.40 during trading on Wednesday, reaching $51.99. The company had a trading volume of 3,469,024 shares, compared to its average volume of 2,381,044. Sanofi has a 52 week low of $45.80 and a 52 week high of $60.12. The company has a market cap of $131.34 billion, a P/E ratio of 20.88, a PEG ratio of 1.01 and a beta of 0.55. The business has a 50 day moving average of $52.54 and a 200 day moving average of $51.90. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14.

Sanofi (NASDAQ:SNY - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $0.94 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.04. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. The company had revenue of $10.41 billion during the quarter, compared to the consensus estimate of $9.79 billion. During the same period in the prior year, the firm earned $1.78 earnings per share. Sanofi's revenue was down 11.0% on a year-over-year basis. As a group, sell-side analysts forecast that Sanofi will post 4.36 earnings per share for the current fiscal year.

Sanofi Increases Dividend

The firm also recently announced an annual dividend, which will be paid on Thursday, June 12th. Shareholders of record on Friday, May 9th will be paid a dividend of $2.0369 per share. This is an increase from Sanofi's previous annual dividend of $1.48. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 3.1%. Sanofi's dividend payout ratio (DPR) is currently 57.14%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.